Trump's Ex-Surgeon General Warns RFK's Move Could Cost Lives

The Controversial Decision to Cut Funding for mRNA Vaccine Development

The decision by Robert F. Kennedy Jr., the U.S. Health Secretary, to cut nearly $500 million in federal funding for the development of mRNA vaccines has sparked significant controversy. This move has drawn sharp criticism from former public health officials and medical experts, who argue that it could have serious consequences for future pandemic preparedness.

Kennedy’s decision halted 22 projects focused on respiratory viruses such as COVID-19 and influenza. Federal contracts with major pharmaceutical companies like Pfizer, Moderna, and Sanofi were also impacted. Additionally, investments managed by the Biomedical Advanced Research and Development Authority (BARDA) were affected. These actions have raised concerns about the potential long-term effects on vaccine research and development.

Kennedy, a known vaccine conspiracy theorist, claimed that mRNA technology does not “perform well against viruses that infect the upper respiratory tract.” He further argued that these vaccines “can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine.” These statements have been widely criticized by scientists and medical professionals, who emphasize that mRNA technology has proven to be highly effective in combating viral threats.

Criticism from Former Surgeon General

Jerome Adams, who served as surgeon general during much of President Donald Trump’s first term, strongly criticized Kennedy’s decision. In a post on X, Adams stated that the move would “cost lives.” He pointed out that mRNA technology has applications beyond vaccines and that the vaccine developed in record time was credited with saving millions of lives.

Adams also echoed the concerns of infectious diseases doctor Jake Scott, who noted that the idea that mRNA vaccines “failed” because they didn’t block all respiratory infections reveals a fundamental misunderstanding of immunology. Scott emphasized that no vaccine for flu, RSV, or COVID has ever aimed to prevent all infections. Instead, the goal is to prevent severe disease, which mRNA vaccines have successfully achieved.

The Broader Implications

Adams agreed with Scott’s assessment and added that part of the blame lies in the messaging around vaccines. He highlighted the common narrative that “if you get this vaccine you won’t get Covid,” which he believes has contributed to misinformation.

In another thread, Adams praised the role of mRNA research in developing the COVID vaccines in “record time” and saving millions of lives. He warned that cutting half a billion dollars in mRNA funding is not just bad policy—it’s dangerous. Adams emphasized that attacking mRNA research means “turning our backs” on more than just COVID vaccines.

He pointed out that the platform is being used to develop vaccines and therapies for a wide range of conditions, including:

• Flu
• RSV
• HIV
• Zika
• Cancer (yes, cancer)
• Autoimmune diseases

Ending or politicizing support for this research risks all of these areas and could undermine the ability to respond to future pandemics.

A Growing Concern

The controversy surrounding Kennedy’s decision has sparked broader discussions about the role of political influence in public health policy. Critics argue that decisions based on misinformation or ideology rather than scientific evidence can have devastating consequences. As the debate continues, the importance of supporting evidence-based research and development remains a critical issue for public health officials and the scientific community.